Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Neutrophil Recruitment Is Regulated By Adamts-13 in a Murine Model of Invasive Aspergillosis

Astrid Hasibeder, Steve Prüfer, Katharina Ebner, Sebastian Reuter, Pamela Stein, Inge Scharrer, Fumiaki Banno, Michael Stassen, Hansjörg Schild, Kerstin Jurk, Markus Bosmann, Markus P. Radsak

Blood (2015) 126 (23): 1010.

https://doi.org/10.1182/blood.V126.23.1010.1010

Published: 2015

Journal Articles

ADAMTS13 Regulates Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Markus Radsak, MD, Steve Prüfer, PhD, Katharina Ebner, Michael Weber, PhD, Sebastian Reuter, PhD, Pamela Stein, PhD, Inge Scharrer, MD, Michael Stassen, PhD, Hansjörg Schild, PhD, Kerstin Jurk, PhD, Markus Bosmann, MD

Blood (2014) 124 (21): 4109.

https://doi.org/10.1182/blood.V124.21.4109.4109

Published: 2014

Journal Articles

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment Of Von Willebrand Disease

Sonja Alesci, MD, Mario Von Depka, Jennifer Feddern, Susan Halimeh, MD, Oliver Hegener, PhD, Janos Kadar, Wolfgang A. Miesbach, MD, PhD, Ulrike Nowak-Göttl, Inge Scharrer, MD, PhD

Blood (2013) 122 (21): 4775.

https://doi.org/10.1182/blood.V122.21.4775.4775

Published: 2013

Journal Articles

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, Non-Interventional Study (wilate ® -SET)

Oliver Hegener, PhD, Inge Scharrer, MD, PhD, Jennifer Feddern, Wolfgang A. Miesbach V, MD, PhD, Mario Von Depka, Janos Kadar

Blood (2012) 120 (21): 4630.

https://doi.org/10.1182/blood.V120.21.4630.4630

Published: 2012

Journal Articles

An Evaluation of Fibrin(ogen) Determinants of Thromboelastography

Dennis K. Galanakis, MD, Miriam Rafailovich, Ph D, Tahmeena Ahmed, MD, Suphanne Pongkitwitoon, MS, Inge Scharrer, MD, PhD, Bohdan Kudryk, Ph D

Blood (2011) 118 (21): 2251.

https://doi.org/10.1182/blood.V118.21.2251.2251

Published: 2011

Journal Articles

Investigation of Side Effects of Plasmaexchange In the Treatment of Thrombotic Thrombocytopenic Purpura

Sarah Steinemann, Tanja Falter, Mirjeta Qorraj, Thomas Vigh, Inge Scharrer, MD, PhD

Blood (2010) 116 (21): 4661.

https://doi.org/10.1182/blood.V116.21.4661.4661

Published: 2010

Journal Articles

ADAMTS13 In 4 Different VWF/VIII Concentrates and Its Impact on Therapy.

Mirjeta Qorraj, Tanja Falter, Sarah Steinemann, Thomas Vigh, Inge Scharrer, MD, PhD

Blood (2010) 116 (21): 3677.

https://doi.org/10.1182/blood.V116.21.3677.3677

Published: 2010

Journal Articles

Evaluation of Clotting Factor Concentrates for Treatment of Thrombotic Thrombocytopenic Purpura.

Tanja Falter, Mirjeta Qorraj, Sarah Steinemann, Thomas Vigh, Inge Scharrer, MD, PhD

Blood (2010) 116 (21): 3678.

https://doi.org/10.1182/blood.V116.21.3678.3678

Published: 2010

Journal Articles

Mild Congenital ADAMTS13 Deficiency in a Patient with Familial Recurrent Ischemic Stroke

Barbara Plaimauer, Susanna Skalicky, Martina Boehm-Weigert, Inge Scharrer, Friedrich Scheiflinger

Blood (2008) 112 (11): 4553.

https://doi.org/10.1182/blood.V112.11.4553.4553

Published: 2008

Journal Articles

Identification of Trigger Factors Initiating an Acute TTP Episode in 68 Patients.

Charis von Auer, MD, Andreas Wilken, MD, Inge Scharrer

Blood (2007) 110 (11): 3969.

https://doi.org/10.1182/blood.V110.11.3969.3969

Published: 2007

Journal Articles

Five Novel Mutations in F13B Gene Resulting in FXIII Deficiency.

Vytautas Ivaskevicius, MD, Hannelore Rott, MD, Inge Scharrer, MD, PhD, Manuela Krause, MD, Erhard Seifried, MD, PhD, Johannes Oldenburg, MD, PhD

Blood (2007) 110 (11): 2150.

https://doi.org/10.1182/blood.V110.11.2150.2150

Published: 2007

Journal Articles

Investigations on the Importance and Prevalence of the Acquired von Willebrand Syndrome in Patients with Myeloproliferative Disease.

Inge Scharrer, Caroline Flick

Blood (2007) 110 (11): 4643.

https://doi.org/10.1182/blood.V110.11.4643.4643

Published: 2007

Journal Articles

Prevention of Complete TTP Relapses by Immediate Initiation of Rituximab Treatment.

Charis von Auer, MD, Georg Hess, MD, Inge Scharrer

Blood (2007) 110 (11): 3203.

https://doi.org/10.1182/blood.V110.11.3203.3203

Published: 2007

Journal Articles

Efficacy of Peri- and Postoperative Treatment in 95 Patients with Von Willebrand’s Disease.

Charis von Auer, MD, Kathrin Lotter, Sandra Heinsdorf, Inge Scharrer, MD

Blood (2006) 108 (11): 4075.

https://doi.org/10.1182/blood.V108.11.4075.4075

Published: 2006

Journal Articles

Response to Anti CD20 Monoclonal Antibody Rituximab® and Epitope Mapping of Inhibitory Antibodies in Patients with Acquired Haemophilia.

Manuela Krause, MD, Christoph Koenigs, MD, Christoph Kessel, Inge Scharrer, MD, Ralf Grossmann, MD, Wolfhard Kreuz, MD

Blood (2006) 108 (11): 1044.

https://doi.org/10.1182/blood.V108.11.1044.1044

Published: 2006

Journal Articles

Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection.

Charis von Auer, MD, Sandra Heinsdorf, Manuela Krause, MD, Wolfgang Miesbach, MD, Inge Scharrer, MD

Blood (2006) 108 (11): 4056.

https://doi.org/10.1182/blood.V108.11.4056.4056

Published: 2006

Journal Articles

ADAMTS-13 Activity and Antigen in Commercial Von Willebrand Factor Concentrates.

Inge Scharrer, MD, Martina Böhm, PhD

Blood (2005) 106 (11): 4027.

https://doi.org/10.1182/blood.V106.11.4027.4027

Published: 2005

Journal Articles

Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis.

Manuela Krause, MD, Charis von Auer, MD, Andreas Kurth, MD, Martina Boehm, MD, L. Hovy, MD, Inge Scharrer, MD

Blood (2005) 106 (11): 4072.

https://doi.org/10.1182/blood.V106.11.4072.4072

Published: 2005

Journal Articles

Factor VIII Inhibitors in Haemophilia A Patients after Continuous Infusion of Factor VIII Concentrates.

Charis von Auer, MD, Johannes Oldenburg, MD, Manuela Krause, MD, Wolfgang Miesbach, MD, Inge Scharrer, CI-Study Group in Germany

Blood (2005) 106 (11): 3198.

https://doi.org/10.1182/blood.V106.11.3198.3198

Published: 2005

Journal Articles

Congenital Dysfibrinogenemia - Clinical Manifestations in Relation to the Fibrinogen Gene Mutation.

Wolfgang A. Miesbach, MD, D. K. Galanakis, MD, Inge Scharrer, MD

Blood (2005) 106 (11): 2138.

https://doi.org/10.1182/blood.V106.11.2138.2138

Published: 2005

NARROW

Neutrophil Recruitment Is Regulated By Adamts-13 in a Murine Model of Invasive Aspergillosis

ADAMTS13 Regulates Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Final Evaluation Of a Prospective, Non-Interventional Study On Efficacy and Tolerability Of a New Generation VWF/FVIII Concentrate In The Treatment Of Von Willebrand Disease

Descriptive Evaluation of Age-Related Differences in Clinical Manifestation and Treatment of Von Willebrand's Disease in an Open-Label, Prospective, Non-Interventional Study (wilate ® -SET)

An Evaluation of Fibrin(ogen) Determinants of Thromboelastography

Investigation of Side Effects of Plasmaexchange In the Treatment of Thrombotic Thrombocytopenic Purpura

ADAMTS13 In 4 Different VWF/VIII Concentrates and Its Impact on Therapy.

Evaluation of Clotting Factor Concentrates for Treatment of Thrombotic Thrombocytopenic Purpura.

Mild Congenital ADAMTS13 Deficiency in a Patient with Familial Recurrent Ischemic Stroke

Identification of Trigger Factors Initiating an Acute TTP Episode in 68 Patients.

Five Novel Mutations in F13B Gene Resulting in FXIII Deficiency.

Investigations on the Importance and Prevalence of the Acquired von Willebrand Syndrome in Patients with Myeloproliferative Disease.

Prevention of Complete TTP Relapses by Immediate Initiation of Rituximab Treatment.

Efficacy of Peri- and Postoperative Treatment in 95 Patients with Von Willebrand’s Disease.

Response to Anti CD20 Monoclonal Antibody Rituximab® and Epitope Mapping of Inhibitory Antibodies in Patients with Acquired Haemophilia.

Hepatocellular Carcinoma in Patients with Hemophilia and Chronic Hepatitis C Infection.

ADAMTS-13 Activity and Antigen in Commercial Von Willebrand Factor Concentrates.

Evaluation of Thrombotic Events in Haemophiliacs Undergoing Major Orthopaedic Surgery without Thrombosis Prophylaxis.

Factor VIII Inhibitors in Haemophilia A Patients after Continuous Infusion of Factor VIII Concentrates.

Congenital Dysfibrinogenemia - Clinical Manifestations in Relation to the Fibrinogen Gene Mutation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only